The anti-endotoxic effects of the KSL-W decapeptide on Escherichia coli O55:B5 and various oral lipopolysaccharides

Journal of Periodontal Research

Volumn 43, Issue 4, 2008, Pages 422-430

  Dixon, D R ^a   Karimi Naser, L ^b   Darveau, R P ^b   Leung, K P ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antimicrobial peptide; Innate immunity; Lipopolysaccharide; Oral bacteria

Indexed keywords

BLOOD CLOTTING FACTOR; DEPSIPEPTIDE; DIAGNOSTIC AGENT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTOXIN; ENZYME PRECURSOR; FACTOR C; FLUORESCENT DYE; LIPOPOLYSACCHARIDE; LIPOPOLYSACCHARIDE, E COLI O55 B5; LIPOPOLYSACCHARIDE, E COLI O55-B5; LYSYL LYSYL VALYL VALYL PHENYLALANYL LYSYL VALYL LYSYL PHENYLALANYL LYSINE; LYSYL-LYSYL-VALYL-VALYL-PHENYLALANYL-LYSYL-VALYL-LYSYL-PHENYLALANYL-LYSINE; SERINE PROTEINASE;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMAL; ARTICLE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; ENDOTHELIUM CELL; ERYTHROCYTE; ESCHERICHIA COLI; FUSOBACTERIUM NUCLEATUM; HEMAGGLUTINATION; HUMAN; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; RABBIT; VASCULAR ENDOTHELIUM;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ANIMALS; BLOOD COAGULATION FACTORS; DEPSIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; E-SELECTIN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; ENDOTOXINS; ENZYME PRECURSORS; ERYTHROCYTES; ESCHERICHIA COLI; FLUORESCENT DYES; FUSOBACTERIUM NUCLEATUM; HEMAGGLUTINATION; HUMANS; LIPOPOLYSACCHARIDES; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; RABBITS; SERINE ENDOPEPTIDASES;

EID: 45549100583     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2007.01067.x     Document Type: Article

References (58)

1. Hancock RE, Brown KL, Mookherjee N. Host defence peptides from invertebrates - emerging antimicrobial strategies. Immunobiology 2006 211 : 315 322.
2. Rosenfeld Y, Shai Y. Lipopolysaccharide (endotoxin)-host defense antibacterial peptides interactions: role in bacterial resistance and prevention of sepsis. Biochim Biophys Acta 2006 1758 : 1513 1522.
3. Ulevitch RJ, Tobias PS. Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin. Annu Rev Immunol 1995 13 : 437 457.
4. Glauser MP, Zanetti G, Baumgartner JD, Cohen J. Septic shock: pathogenesis. Lancet 1991 338 : 732 736.
5. Watson RW, Redmond HP, Bouchier-Hayes D. Role of endotoxin in mononuclear phagocyte-mediated inflammatory responses. J Leukoc Biol 1994 56 : 95 103.
6. Kirschning CJ, Bauer S. Toll-like receptors: cellular signal transducers for exogenous molecular patterns causing immune responses. Int J Med Microbiol 2001 291 : 251 260.
7. Ulevitch RJ, Mathison JC, Schumann RR, Tobias PS. A new model of macrophage stimulation by bacterial lipopolysaccharide. J Trauma 1990 30 : S189 S192.
8. Dixon DR, Darveau RP. Lipopolysaccharide heterogeneity: innate host responses to bacterial modification of lipid a structure. J Dent Res 2005 84 : 584 595.
9. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000 406 : 782 787.
10. Calandra T. Pathogenesis of septic shock: implications for prevention and treatment. J Chemother 2001 13 (Spec. No. 1): 173 180.
11. Epand RM, Vogel HJ. Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1999 1462 : 11 28.
12. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002 415 : 389 395.
13. Bowdish DM, Davidson DJ, Scott MG, Hancock RE. Immunomodulatory activities of small host defense peptides. Antimicrob Agents Chemother 2005 49 : 1727 1732.
14. Devine DA. Antimicrobial peptides in defence of the oral and respiratory tracts. Mol Immunol 2003 40 : 431 443.
15. Giangaspero A, Sandri L, Tossi A. Amphipathic alpha helical antimicrobial peptides. Eur J Biochem 2001 268 : 5589 5600.
16. Li P, Wohland T, Ho B, Ding JL. Perturbation of lipopolysaccharide (LPS) micelles by Sushi 3 (S3) antimicrobial peptide. The importance of an intermolecular disulfide bond in S3 dimer for binding, disruption, and neutralization of LPS. J Biol Chem 2004 279 : 50150 50156.
17. Rosenfeld Y, Papo N, Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J Biol Chem 2006 281 : 1636 1643.
18. Thomas CJ, Surolia N, Surolia A. Kinetic and thermodynamic analysis of the interactions of 23-residue peptides with endotoxin. J Biol Chem 2001 276 : 35701 35706.
19. Hong SY, Park TG, Lee KH. The effect of charge increase on the specificity and activity of a short antimicrobial peptide. Peptides 2001 22 : 1669 1674.
20. Oh JE, Hong SY, Lee KH. Structure-activity relationship study: short antimicrobial peptides. J Pept Res 1999 53 : 41 46.
21. Concannon SP, Crowe TD, Abercrombie JJ et al. Susceptibility of oral bacteria to an antimicrobial decapeptide. J Med Microbiol 2003 52 : 1083 1093.
22. Leung KP, Crowe TD, Abercrombie JJ et al. Control of oral biofilm formation by an antimicrobial decapeptide. J Dent Res 2005 84 : 1172 1177.
23. Na DH, Faraj J, Capan Y, Leung KP, Deluca PP. Stability of antimicrobial decapeptide (KSL) and its analogues for delivery in the oral cavity. Pharm Res 2007 24 : 1544 1550.
24. Yi EC, Hackett M. Rapid isolation method for lipopolysaccharide and lipid A from gram-negative bacteria. Analyst 2000 125 : 651 656.
25. Darveau RP, Hancock RE. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 1983 155 : 831 838.
26. Bantroch S, Buhler T, Lam JS. Appropriate coating methods and other conditions for enzyme-linked immunosorbent assay of smooth, rough, and neutral lipopolysaccharides of Pseudomonas aeruginosa. Clin Diagn Lab Immunol 1994 1 : 55 62.
27. Freudenberg MA, Fomsgaard A, Mitov I, Galanos C. ELISA for antibodies to lipid A, lipopolysaccharides and other hydrophobic antigens. Infection 1989 17 : 322 328.
28. Darveau RP, Cunningham MD, Bailey T et al. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect Immun 1995 63 : 1311 1317.
29. Ebisawa M, Bochner BS, Georas SN, Schleimer RP. Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1 beta-induced transendothelial migration. J Immunol 1992 149 : 4021 4028.
30. Kirikae T, Inada K, Hirata M, Yoshida M, Galanos C, Luderitz O. Hemagglutination induced by lipopolysaccharides and lipid A. Microbiol Immunol 1986 30 : 269 274.
31. Neter E, Zalewski NJ, Ferguson WW. Escherichia coli hemagglutinin response of adult volunteers to ingested E. coli 055 B5. Proc Soc Exp Biol Med 1953 82 : 215 219.
32. Neter E. Bacterial hemagglutination and hemolysis. Bacteriol Rev 1956 20 : 166 188.
33. Alam M, Miyoshi S, Tomochika K, Shinoda S. Hemagglutination is a novel biological function of lipopolysaccharide (LPS), as seen with the Vibrio cholerae O139 LPS. Clin Diagn Lab Immunol 1997 4 : 604 606.
34. Leung KP, Fukushima H, Nesbitt WE, Clark WB. Prevotella intermedia fimbriae mediate hemagglutination. Oral Microbiol Immunol 1996 11 : 42 50.
35. Okamoto M, Maeda N, Kondo K, Leung KP. Hemolytic and hemagglutinating activities of Prevotella intermedia and Prevotella nigrescens. FEMS Microbiol Lett 1999 178 : 299 304.
36. Scott MG, Yan H, Hancock RE. Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect Immun 1999 67 : 2005 2009.
37. Macias EA, Rana F, Blazyk J, Modrzakowski MC. Bactericidal activity of magainin 2: use of lipopolysaccharide mutants. Can J Microbiol 1990 36 : 582 584.
38. Srimal S, Surolia N, Balasubramanian S, Surolia A. Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A. Biochem J 1996 315 (Pt 2): 679 686.
39. Thomas CJ, Surolia A. Kinetics of the interaction of endotoxin with polymyxin B and its analogs: a surface plasmon resonance analysis. FEBS Lett 1999 445 : 420 424.
40. Frey EA, Miller DS, Jahr TG et al. Soluble CD14 participates in the response of cells to lipopolysaccharide. J Exp Med 1992 176 : 1665 1671.
41. Hailman E, Lichenstein HS, Wurfel MM et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 1994 179 : 269 277.
42. Alam M, Miyoshi SI, Tomochika KI, Shinoda S. Purification and characterization of novel hemagglutinins from Vibrio mimicus: a 39-kilodalton major outer membrane protein and lipopolysaccharide. Infect Immun 1996 64 : 4035 4041.
43. Ogawa T, Suda Y, Kashihara W et al. Immunobiological activities of chemically defined lipid A from Helicobacter pylori LPS in comparison with Porphyromonas gingivalis lipid A and Escherichia coli-type synthetic lipid A (compound 506). Vaccine 1997 15 : 1598 1605.
44. Ernst RK, Yi EC, Guo L et al. Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa. Science 1999 286 : 1561 1565.
45. Ogawa T. Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide. FEBS Lett 1993 332 : 197 201.
46. Ogawa T, Uchida H, Amino K. Immunobiological activities of chemically defined lipid A from lipopolysaccharides of Porphyromonas gingivalis. Microbiology 1994 140 (Pt 5): 1209 1216.
47. Cohen J, McConnell JS. Antibiotic-induced endotoxin release. Lancet 1985 2 : 1069 1070.
48. Shenep JL, Barton RP, Mogan KA. Role of antibiotic class in the rate of liberation of endotoxin during therapy for experimental gram-negative bacterial sepsis. J Infect Dis 1985 151 : 1012 1018.
49. Glauser MP. Pathophysiologic basis of sepsis: considerations for future strategies of intervention. Crit Care Med 2000 28 : S4 S8.
50. Zanetti G, Baumgartner JD, Glauser MP. Sepsis and septic shock. Schweiz Med Wochenschr 1997 127 : 489 499.
51. Hirata M, Shimomura Y, Yoshida M, Wright SC, Larrick JW. Endotoxin-binding synthetic peptides with endotoxin-neutralizing, antibacterial and anticoagulant activities. Prog Clin Biol Res 1994 388 : 147 159.
52. Nagaoka I, Hirota S, Niyonsaba F et al. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues. Clin Diagn Lab Immunol 2002 9 : 972 982.
53. Gough M, Hancock RE, Kelly NM. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun 1996 64 : 4922 4927.
54. Hirakura Y, Kobayashi S, Matsuzaki K. Specific interactions of the antimicrobial peptide cyclic beta-sheet tachyplesin I with lipopolysaccharides. Biochim Biophys Acta 2002 1562 : 32 36.
55. Storm DR, Rosenthal KS, Swanson PE. Polymyxin and related peptide antibiotics. Annu Rev Biochem 1977 46 : 723 763.
56. Falla TJ, Karunaratne DN, Hancock RE. Mode of action of the antimicrobial peptide indolicidin. J Biol Chem 1996 271 : 19298 19303.
57. Scott MG, Vreugdenhil AC, Buurman WA, Hancock RE, Gold MR. Cutting edge: cationic antimicrobial peptides block the binding of lipopolysaccharide (LPS) to LPS binding protein. J Immunol 2000 164 : 549 553.
58. Ohashi K, Niwa M, Nakamura T, Morita T, Iwanaga S. Anti-LPS factor in the horseshoe crab, Tachypleus tridentatus. Its hemolytic activity on the red blood cell sensitized with lipopolysaccharide. FEBS Lett 1984 176 : 207 210.